MSc MSc - Novozymes A/S Ex CFO
| NVZMF Stock | USD 57.50 0.35 0.61% |
Insider
MSc MSc is Ex CFO of Novozymes AS B
| Age | 56 |
| Phone | 45 44 46 00 00 |
| Web | https://www.novozymes.com |
Novozymes A/S Management Efficiency
The company has return on total asset (ROA) of 0.1062 % which means that it generated a profit of $0.1062 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2789 %, meaning that it generated $0.2789 on every $100 dollars invested by stockholders. Novozymes A/S's management efficiency ratios could be used to measure how well Novozymes A/S manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Elizabeth Simermeyer | Ecolab Inc | 56 | |
| Batrice FavreBulle | Symrise Ag PK | N/A | |
| Leslie McGibbon | Akzo Nobel NV | N/A | |
| Andrew Hedberg | Ecolab Inc | N/A | |
| Randell McShepard | RPM International | N/A | |
| Klaas Kruithof | Akzo Nobel NV | N/A | |
| Gregoire PouxGuillaume | Akzo Nobel NV | 53 | |
| Alberto Weisser | Linde plc Ordinary | 65 | |
| Gail Peterson | Ecolab Inc | 45 | |
| MSc MBA | Sika AG ADR | 68 | |
| Laurent Pieren | Givaudan SA | N/A | |
| Franois Abrial | LAir Liquide SA | 61 | |
| Wayne Smith | Air Products and | 60 | |
| Tonit Calaway | Air Products and | 53 | |
| Alexander Boo | Ecolab Inc | 53 | |
| Executive MBA | Sika AG | 58 | |
| Scott Copeland | RPM International | N/A | |
| Fabien Jaunault | Givaudan SA | N/A | |
| Brian Padden | Sherwin Williams Co | 48 | |
| Luz Granizo | Sika AG | N/A | |
| Jrme Pelletan | LAir Liquide SA | 53 | |
Management Performance
| Return On Equity | 0.28 | |||
| Return On Asset | 0.11 |
Novozymes AS B Leadership Team
Elected by the shareholders, the Novozymes A/S's board of directors comprises two types of representatives: Novozymes A/S inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novozymes. The board's role is to monitor Novozymes A/S's management team and ensure that shareholders' interests are well served. Novozymes A/S's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novozymes A/S's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pedro Fernandes, Head America | ||
| Tobias Bjorklund, Head of Investor Relations | ||
| Ester Baiget, Pres CEO | ||
| Tue Micheelsen, VP Marketing | ||
| Sebastian Sderberg, VP Acquisitions | ||
| Tina Fanoe, Executive Vice President Agriculture & Bioenergy | ||
| Graziela Malucelli, Supply Operations | ||
| Anders Lund, Executive Vice President Household Care & Technical Industries | ||
| Morten Rasmussen, Sustainability People | ||
| MSc MSc, Ex CFO |
Novozymes Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Novozymes A/S a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.28 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 14.47 B | |||
| Shares Outstanding | 222.86 M | |||
| Shares Owned By Insiders | 8.04 % | |||
| Shares Owned By Institutions | 42.30 % | |||
| Price To Earning | 33.38 X | |||
| Price To Book | 6.19 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Novozymes Pink Sheet
Novozymes A/S financial ratios help investors to determine whether Novozymes Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novozymes with respect to the benefits of owning Novozymes A/S security.